Anthony Letai, MD, PhD, FAACR, Lays Out NCI’s Priorities at the AACR Annual Meeting 2026
At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to...
At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
The AACR Annual Meeting 2025, held April 25-30, featured six Plenary Sessions that explored exciting areas of cancer research,...
Takeaways from day 4 of the AACR Annual Meeting 2025 include declining breast cancer mortality, using liquid and tissue...
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
Cancer screenings are key to saving lives. Take colonoscopies, for example, which are estimated to reduce colorectal cancer risk...
At the 2024 San Antonio Breast Cancer Symposium, researchers discussed clinical trials for vaccines and other ways to prevent...
This quarter's round-up of cutting-edge cancer research includes a way to fight chemo brain, controlling cancer cell death, and...
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.